Companies
ResMed
a publicly traded medical-device company manufacturing clinical sleep-apnea (CPAP) therapy devices, reporting quarterly earnings and continuing to unveil new digital and personalized sleep-health solutions.
- Country
- United States
- Ticker
- RMD
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | $5.7 billion for fiscal year 2026 (2026-06-30) | sec.gov |
| Headcount | approximately 11,370 people (2026-06-30) | investor.resmed.com |
| Production site | Tuas, Singapore; Sydney, Australia; Chatsworth, California; Calabasas, California; Johor Bahru, Malaysia; Atlanta, Georgia; Suzhou, China; Lyon, France (2026-06-30) | investor.resmed.com |
| Certification | ISO 13485; MDSAP; ISO 14001:2015 for Sydney and Singapore sites (2026-06-30) | investor.resmed.com |
| Capacity | facility in Tuas, Singapore significantly increased production capacity of masks and serves as primary production location for AirSense 11 device (2022-11-17) | newsroom.resmed.com |
Independent sources: sec.gov
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Sleep and circadian bioeconomy | diagnostics-medtech | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.